FILE:HCP/HCP-8K-20090904163248.txt.gz
EVENTS:	Other Events	Financial Statements and Exhibits
TEXT:
ITEM: Other Events
ITEM: Financial Statements and Exhibits
 
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o
           
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 240.425)
 
o
           
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o
           
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o
           
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
Item 8.01.
                                        
Other Events
 
On September 4, 2009, HCP, Inc. (the "Company") issued a press release with respect to the jury verdict rendered in connection with the complaint filed by Ventas, Inc. against the Company.  The press release is filed as Exhibit 99.1 to this report and is incorporated herein by reference.
 
Item 9.01
                                           
Financial Statements and Exhibits.
 
(d)
                                                        
Exhibits
 
99.1
                                                  
Press Release dated September 4, 2009
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
Attached as exhibits to this Current Report on Form 8-K are the documents listed below:
 

Exhibit 99.1
 
 
HCP ANNOUNCES JURY VERDICT IN VENTAS LITIGATION
 
LONG BEACH, CA  September 4, 2009  HCP (NYSE:HCP) announced that a jury reached a verdict in favor of Ventas, Inc., in an action brought against HCP in the United States District Court for the Western District of Kentucky for tortious interference with prospective business advantage in connection with Ventas's 2007 acquisition of Sunrise Senior Living REIT.  The jury awarded Ventas approximately $101 million in compensatory damages.  During the trial, the court dismissed Ventas's claims for punitive damages.  Ventas originally sought approximately $300 million in compensatory damages as well as punitive damages.  HCP will appeal the adverse jury verdict.
 
ABOUT HCP
 
HCP, Inc., an S&P 500 company, is a real estate investment trust (REIT) that, together with its consolidated subsidiaries, invests primarily in real estate serving the healthcare industry in the United States.  As of June 30, 2009, HCP's portfolio of properties, excluding assets held for sale but including properties owned by unconsolidated joint ventures, totaled 682 properties among the following segments: 259 senior housing, 100 life science, 253 medical office, 22 hospital and 48 skilled nursing. For more information, visit the Company's website at www.hcpi.com.
 
FORWARD-LOOKING STATEMENTS
 
The statements contained in this release which are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.  These statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in or implied by forward-looking statements.  These risks and uncertainties include the risks associated with litigation in general, including the costs and time that must be devoted to litigation, the potential diversion of management attention that may result from being engaged in litigation, the potential outcome of any appeal and the possibility of larger than expected litigation costs, and other risks and uncertainties detailed from time to time in the Company's filings with the Securities and Exchange Commission. While the Company anticipates that subsequent events and developments may cause its views to change, it specifically disclaims any obligation to update these statements.  These statements should not be relied upon as representing the Company's views as of any date subsequent to the date of this press release.
 
CONTACT
:
 
HCP Thomas M. Herzog Executive Vice President  Chief Financial Officer and Treasurer 562-733-5309
 


